Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC — Stella

Home/Urothelial Carcinoma/Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

View on ClinicalTrials.gov

Recruiting

Back to Urothelial Carcinoma trials

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

Trial locations(3 sites)

China

Departmeng of Urology, Peking University First Hospital, Beijing

Department of Medical Oncology, Peking University First Hospital, Beijing

Department of Radiotherapy Oncology, Peking University First Hospital, Beijing

Key details

Sponsor

Peking University First Hospital

Enrollment target

~178 participants

Started

January 2022

Primary completion

June 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.